Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
Camacho-Toledano C, Machín-Díaz I, Calahorra L, Cabañas-Cotillas M, Otaegui D, Castillo-Triviño T, Villar LM, Costa-Frossard L, Comabella M, Midaglia L, García-Domínguez JM, García-Arocha J, Ortega MC, Clemente D.
Camacho-Toledano C, et al. Among authors: clemente d.
J Neuroinflammation. 2022 Nov 19;19(1):277. doi: 10.1186/s12974-022-02635-3.
J Neuroinflammation. 2022.
PMID: 36403026
Free PMC article.